NTV Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.4M Sell
246,758
-1,742
-0.7% -$78.3K 1.24% 14
2026
Q2
$10.5M Buy
248,500
+59,909
+32% +$1.91M 1.02% 21
2026
Q1
$4.98M Buy
188,591
+3,035
+2% +$88.9K 0.55% 51
2025
Q4
$5.38M Buy
185,556
+25,360
+16% +$761K 0.57% 47
2025
Q3
$4.45M Buy
+160,196
New +$4.05M 0.49% 60

Other funds holding ARKG

NTV Asset Management's ARKG Position: Q3 2026 in Review

NTV Asset Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.7% in Q3 2026, selling an estimated $78.3K and leaving 246,758 shares worth $13.4M. The position accounts for 1.24% of the portfolio, ranked #14.

NTV Asset Management first reported a position in ARKG in Q3 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • NTV Asset Management held 246,758 shares of ARK Genomic Revolution ETF worth $13.4M as of Q3 2026.
  • NTV Asset Management sold 1,742 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $78.3K.
  • ARK Genomic Revolution ETF made up 1.24% of NTV Asset Management's portfolio in Q3 2026, its #14 holding.
  • NTV Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on NTV Asset Management's 13F filing for Q3 2026, filed 23 Oct 2026.